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Background: Prolonged Exposure (PE) therapy is an efficacious treatment for
PTSD; despite this, many clinicians do not utilize it due to concerns it could
cause patient decompensation. Method: Data were pooled from four published
well-controlled studies of female assault survivors with chronic PTSD (n = 361)
who were randomly assigned to PE, waitlist (WL), or another psychotherapy,
including cognitive processing therapy (CPT), Eye Movement and Desensiti-
zation Reprocessing (EMDR), or the combination of PE plus stress inoculation
training (SIT) or PE plus cognitive restructuring. PTSD and depression severity
scores were converted to categorical outcomes to evaluate the proportion of partic-
ipants who showed reliable symptom change (both reliable worsening and reliable
improvement). Results: The majority of participants completing one of the ac-
tive treatments showed reliable improvement on both PTSD and depression
compared to WL. Among treatment participants in general, as well as those
who received PE, reliable PTSD worsening was nonexistent and the rate of
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reliable worsening of depression was low. There were no differences on any
outcome measures among treatments. By comparison, participants in WL had
higher rates of reliable symptom worsening for both PTSD and depression. Po-
tential alternative explanations were also evaluated. Conclusions: PE and a
number of other empirically supported therapies are efficacious and safe treat-
ments for PTSD, reducing the frequency of which symptom worsening occurs in
the absence of treatment. Depression and Anxiety 31:412–419, 2014. C© 2013
Wiley Periodicals, Inc.
Key words: Anxiety; Cognitive Behavioral Therapy; Depression; Exposure
Therapy; PTSD; Trauma; Treatment Outcome
Exposure therapy for posttraumatic stress disorder
(PTSD) typically includes imaginal exposure to the
trauma memory and in vivo exposure to safe but feared
or avoided trauma reminders. Exposure therapy has re-
ceived substantial empirical support for its efﬁcacy,[1,2]
but despite this, many clinicians do not utilize it, fre-
quently due to insufﬁcient training and concerns it could
cause patient decompensation.[3,4]
Empirical support for concerns about the safety of
exposure therapy for PTSD is limited. Based on six
Vietnam veterans unsuccessfully treated with imaginal
exposure, Pitman et al.[5] suggested it is not suitable for
patients displaying negative emotions other than anxiety
(e.g. anger) and that cognitive approaches may be more
beneﬁcial for such patients. Tarrier et al.[6] compared
imaginal exposure with cognitive therapy and found that
on average both treatments were similarly effective at de-
creasing PTSD symptoms. The authors reported that a
signiﬁcantly greater number of patients receiving imag-
inal exposure worsened over treatment (31 vs. 9.1%),
with symptomworsening deﬁned as an increase of one or
more points on the Clinician Administered PTSD Scale
(CAPS). At the 6-month follow-up assessment, however,
no signiﬁcant differences between groups emerged.
Devilly and Foa[7] noted a number of methodological
problems that complicate interpretation of the Tarrier
et al.[6] ﬁndings. First, they questioned the exclusive re-
liance on a single outcome measure (i.e. the CAPS) for
deﬁning symptom worsening when the study included
other relevant measures (e.g. the Impact of Events Scale;
the Penn Inventory for PTSD) on which no differen-
tial rates of worsening emerged. Second, given the mea-
surement error associated with the CAPS, they ques-
tioned whether participants showing minimal increases
in CAPS scores can be viewed as having experienced
symptom worsening. To address these problems, Dev-
illy andFoa[7] proposed an alternative operational deﬁni-
tion of symptom change, termed “reliable change,” that
is based on the standard error of the differences between
two administrations of the instrument (test–retest), so
to assess for random ﬂuctuations due to measurement
error. Therefore, “reliable worsening” would be a pre-
to posttreatment increase in symptoms larger than the
standard error of the difference between two measure-
ments. Third, as with Pitman et al.,[4] the absence of a
waitlist (WL) condition hampers interpretation of the
Tarrier et al.[6] results, because the percentage of pa-
tients who would experience symptom worsening with-
out treatment is unknown.
In the present study, we examined whether prolonged
exposure (PE), a speciﬁc exposure therapy protocol that
combines imaginal and in vivo exposure, leads to PTSD
symptom worsening using methodology that overcomes
the limitations of previous studies.We accomplished this
by pooling data from four published, well-controlled
clinical trials. Each of the four trials compared PE to
WL and at least one other psychotherapy with demon-
strable efﬁcacy for PTSD that include an element of ex-
posure: cognitive processing therapy (CPT), EyeMove-
ment and Desensitization Reprocessing (EMDR), and
combination treatments of PE plus stress inoculation
training (PE/SIT) or cognitive restructuring (PE/CR).
Participants in all these studies were female assault vic-
tims; we deliberately limited the focus of our study to
this particular population so that the data were homoge-
nous in terms of sampled population. The Devilly and
Foa[7] deﬁnition (termed here “reliable change”) were
used to compare the percentage of participants receiv-
ing PE who showed reliable symptom worsening versus
WL and other treatments. Because withholding treat-
ment may also cause harm by preventing possible im-
provement, we also compared the percentage of partici-
pants who showed reliable improvement in response to
treatment with PE, other active treatments, and WL.
METHOD
STUDIES AND PARTICIPANTS
Wepooled data from four studies conducted by three of the current
authors (E.B.F., P.A.R, and B.O.R [8–11]). All four studies randomly
assigned adult female participants with chronic PTSD to at least nine
sessions of PE,WL, and at least one other active empirically supported
psychotherapeutic intervention that includes some degree of exposure.
One of the studies included SIT as a treatment condition,[8] but these
individuals were excluded from the current analyses as SIT does not
include an exposure element. All studies utilized a reliable and valid
measure of PTSD administered by an independent evaluator blind to
participants’ study condition, as well as a self-reportmeasure of depres-
sion. Finally, all studies took standard steps to insure high treatment
ﬁdelity for all conditions. Inclusion criteria for all the studies included
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TABLE 1. Summary of studies included in current analyses
Measures
Study Condition N Completers
Sample and Target
Trauma N Dropouts (%)
Sessions (#, duration,
frequency) PTSD Depression
Foa et al. (1999) PE 23 Female survivors of rape
and nonsexual assault
after age 16
2 (8%) 9 sessions 90–120 min
2×/week
PSS-I BDI
PE/SIT 22 8 (27%)
WL 15 0 (0%)
Foa et al. (2005) PE 52 Female survivors of
sexual and nonsexual
assault after age 16
and childhood sexual
abuse
27 (34%) 9 –12 sessions 90–120
min 1×/week
PSS-I BDI
PE/CR 44 30 (41%)
WL 25 1 (4%)
Resick et al. (2002) PE 40 Female survivors of rape 15 (27%) PE: 9 sessions 90–120
min, 2×/week
CPT: 12 sessions 60
min, 2×/week
CAPS BDI
CPT 41 15 (27%)
WL 40 7 (15%)
Rothbaum et al. (2005) PE 20 Female survivors of rape 3 (13%) 9 sessions 90–120 min
2×/week
CAPS BDI
EMDR 20 5 (20%)
WL 20 4 (17%)
Note: Foa et al. (2005) reported 25 waitlist completers, but posttreatment PSSI data was not available for one of them; accordingly, only the 24
participants with complete datawere included in the present analyses.Measures of PTSDwere thePTSDSymptomScale Interview (PSS-I)Clinician
Administered PTSD Scale (CAPS), the measure of depression was the Beck Depression Inventory (BDI: all four studies). The treatments were
prolonged exposure (PE), stress inoculation training (SIT), prolonged exposure combined with stress inoculation training (PE/SIT), prolonged
exposure combined with cognitive restructuring (PE/CR), eye movement desensitization and reprocessing (EMDR), and cognitive processing
therapy (CPT); the control condition was waitlist (WL).
a primary diagnosis of PTSD and being a female survivor of assault.
Two studies[8,9] included victims of both sexual and nonsexual assault.
The other two studies[10,11] included only victims of sexual assault. For
all studies, exclusion criteria included current schizophrenia, psychosis
or bipolar disorder; organic mental disorder, alcohol or drug depen-
dency, and severe suicidal ideation/intent. Illiteracy in English was an
exclusion criteria in three studies,[9–11] being in an abusive relationship
in two studies,[9,10] and self-injurious behavior in two studies.[9,11]
The following were exclusion criteria in a single study: current re-
lationship with assailant,[8] developmental disabilities,[10] being less
than six months since the end of a relationship where martial rape took
place,[10] blindness or history of eye disease,[11] use of cocaine within
60 days of receiving treatment,[11] and being in a current threatening
situation.[11] A summary of these four studies is provided in Table 1;
for further details see the published research reports.
Because the goal of this study was to determine if individuals who
received a therapeutic course of PE experienced symptom worsening,
our analyses focused on treatment completers. Moreover, few par-
ticipants who dropped out of treatment returned for a postdropout
evaluation, limiting our ability to evaluate symptom status with a clin-
ical interview for PTSD symptoms.1 Accordingly, participants were
361 female assault survivors that completed participation in the four
1We examined PTSD symptoms for the PSS-SR (12), the self-report
version of the PSS-I, among participants who dropped out of treatment
(PE and PE/CR) in the study with the largest dropout rate (i.e., 32.4%;
[11]). The PSS-SR was administered at the pre-treatment assessment,
at each even numbered therapy session, and at post-treatment. Of 57
participants who dropped out of treatment, 49 had a pre-treatment
PSS-SR plus at least one additional PSS-SR obtained during treat-
ment or at post-treatment. Reliable change for the PSS-SR, obtained
from Foa et al. [22], was +/− 6.15 points. Among treatment dropouts,
59% showed reliable improvement, 16% showed numerical worsen-
ing, and 6% showed reliable worsening. These rates are similar to
what we found for the WL condition in this study, for which the
corresponding rates were 52%, 24%, and 5%. Thus, rates of symp-
studies mentioned above. Participants were distributed as follows: PE
alone, N = 135;[8–11] PE/SIT, N = 22;[8] PE/CR, N = 44;[9] CPT,
N = 41;[10] EMDR, N = 20;[11] andWL, N = 99.[8–11] Pre- and post-
treatment PTSD data were available for 100% of participants and BDI
data were available for 339 (93.9%) of participants.
MEASURES
PTSD was assessed with PTSD Symptom Scale – Interview (PSS-
I[12]) in the two studies by Foa et al.,[8,9] on which scores range be-
tween 0 and 51. The Clinician Administered PTSD Scale (CAPS[13])
was utilized in the studies by Resick et al.[10] and Rothbaum et al.,[11]
on which scores range between 0 and 136. There is a strong corre-
spondence between the two instruments.[14] Depression was assessed
with the Beck Depression Inventory (BDI).[15]
STUDY CONDITIONS
All treatments included basic education in the nature of PTSD and
a rationale for the speciﬁc interventions that would be used. In addition
to patient education, each treatment contained other speciﬁc elements.
Prolonged Exposure. PE comprised training in controlled
breathing (one session), imaginal exposure (IE) to the trauma memory
followed by a discussion of the experience (called processing), and in
vivo exposure to safe but feared or avoided trauma reminders. PE was
administered in either nine, twice weekly 90-min sessions[8,10,11] or
9–12 weekly 90-min sessions, with the number of sessions determined
by the participants’ response to treatment.[9] Homework assignments
consisted of practicing controlled breathing, and both imaginal and in
vivo exposure exercises. Foa, Hembree, and Rothbaum[16] provide a
detailed description of the PE protocol.
tom improvement were lower among treatment dropouts than among
treatment completers, and rates of reliable symptom worsening were
greater for treatment dropouts than for treatment completers. How-
ever, these rates for treatment dropouts are similar to those obtained
for WL participants.
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PE/SIT and PE/CR. PE/SIT followed the nine-session, twice-
weekly format and included education, training in SIT skills, imagi-
nal exposure, and in vivo exposure. The SIT skills were adapted from
the program developed by Veronen and Kilpatrick,[17] consisting of
teaching coping skills to manage assault-related anxiety and postas-
sault problems. Skills included deep muscle relaxation, cue-controlled
and differential relaxation, thought stopping, cognitive restructuring,
guided self-dialogue, covert modeling, and role-playing. PE/CR was
identical to PE as administered in the Foa et al.[9] study with two
exceptions. First, Session 3 focused on CR, thereby delaying the intro-
duction of imaginal exposure until session 4. Second, all subsequent
sessions included both imaginal exposure and CR. PE/CR entailed the
same amount of exposure homework as those in PE, plus daily practice
of CR using a daily diary form. See Foa et al.[9] for more details.
Cognitive Processing Therapy. CPT included two sessions of
written narrative accounts, although it is primarily a trauma-focused
cognitive therapy in which participants are taught to challenge dis-
torted beliefs about the causes and consequences of their traumatic
experience(s). CPT was administered according to the Resick and
Schnicke[18] manual and comprised 12, twice weekly 60-min sessions.
Sessions 7–12 focused on the speciﬁc topics of safety, trust, power-
control, esteem, and intimacy. Homework consisted of writing ex-
ercises about the nature and meaning of the participant’s traumatic
experience and practice challenging trauma-related cognitions with a
sequential series of worksheets and practice assignments.
EyeMovement andDesensitizationReprocessing. Theman-
ual distributed at EMDR training workshops served as the study treat-
ment manual. EMDR involved having the participant imagine a scene
that represented the worst part of the trauma while focusing on bod-
ily sensations of distress and rehearsing negative thoughts that match
the picture. When distress over the memory substantially decreased,
new, preferred beliefs are rehearsed until they feel true to the pa-
tient. This whole process was conducted while the patient tracked
the therapist’s ﬁngers moving back and forth in front of her. EMDR
also utilizes a form of cognitive therapy referred to as the cognitive
interweave.[19] EMDRwas administered in nine, twice weekly 90-min
sessions. Homework assignments were not given.
Waitlist. Participants in the WL conditions were informed they
would receive treatment after a 4–9 week waiting period, depending
on the speciﬁc study in which they were participants.
DEFINITIONS
Reliable worsening was deﬁned as a pre- to posttreatment increase
larger than the standard error of the difference between two
measurements,[7,20] given as SED = SQRT[2(SEM2)], where SEM =
SD*SQRT(1-r), SD is the standard deviation of a reference sample,
and r is the instrument’s test-retest reliability. Reliable improvement
was deﬁned as a pre- to post-treatment decrease larger than one SED.
All other values reﬂected changes too small to be considered reliable.
For the PSS-I, a SD of 11.1 was calculated from a large sample
(N = 196) of female assault survivors assessed approximately 10-weeks
posttrauma, 39.3% of whom met full symptom criteria for PTSD.
A 1-month test–retest reliability coefﬁcient of .77 was computed on
a subsample of the women (n = 184) who completed the measure
again 4 weeks later. Thus, reliable change on the PSS-I was a change
greater than +/− 7.53 points. For the CAPS, McDevitt-Murphy
et al.[21] obtained a 1-week test–retest reliability of .89 in a group
of 55 women exposed to range of potentially traumatic events, 25%
of whom met full symptom criteria for PTSD. Separate SDs were
reported for the PTSD (13.1) and no PTSD (14.9) groups, from
which we computed an overall SD of 24.2. Thus, reliable change
on the CAPS was a change greater than +/− 11.35, similar to the
10-point change Schnurr et al.[22,23] used to reﬂect statistically and
clinically meaningful change. Based on Foa et al.,[20] we adopted a
change greater than +/− 4.53 to indicate reliable change on the BDI.
ANALYTIC STRATEGY
Nonparametric tests (chi-square, Fisher’s Exact Test when one
or more cells had an expected frequency less than ﬁve) were con-
ducted to analyze the study data using SPSS (version 16.0) and
SAS (version 9.2). Conﬁdence intervals for nonparametric tests were
calculated by ﬁrst computing the upper and lower limits of the
noncentrality parameter using NDC.EXE, a freeware available at
http://www.statpower.net/Software.html, and then converting those
values into Cohen’s w.[24]
We investigated reliable symptom change by submitting PTSD and
depression data to separate 2 Group (active treatment, WL) × 3 Out-
come (reliable improvement, no reliable change, reliable worsening)
analyses. Active treatment comprised the pooled results for all treat-
ments. Signiﬁcant effects were followed by separate 2 × 2 analyses to
compare active treatment with WL on relative proportion of reliable
improvement and reliable worsening and PE alone with WL. Next,
separate 2 Type of Treatment (PE alone, combination treatment) × 3
Outcome (reliable improvement, no reliable change, reliable worsen-
ing) analyses were conducted. The combination treatment condition
pooled results from PE/SIT, PE/CR, CPT, and EMDR.
RESULTS
RELIABLE SYMPTOM CHANGE
Table 2 presents the number (percentage) of par-
ticipants showing reliable improvement, no reliable
change, and reliable worsening comparing active treat-
ment with WL for PTSD (top panel) and de-
pression (bottom panel), along with the results of
the initial 2 Group × 3 Outcome analyses. Fisher’s
Exact Tests indicated signiﬁcant differences between
treatment and WL conditions for both PTSD and
depression. The follow-up 2 × 2 analyses indicated that,
compared toWL, active treatment was associated with a
greater proportion of participants achieving reliable im-
provement for both PTSD (91.6 vs. 36.4%; χ2 (1, N =
361) = 121.8, P < .001, η2 = .58, 95% CI [.48, .68]) and
depression (83.1 vs. 36.9%; [χ2 (1, N = 339) = 66.5, p <
.001, η2 = .44, 95%CI [.34, .55]). In addition, compared
withWL, active treatment was associated with a smaller
proportion of participants displaying reliable worsening
for both PTSD (0 vs. 8.1%; Fisher’s Exact Test, P < .001,
N = 361) and depression (1.9 vs. 10.1%; Fisher’s Exact
Test, P < .001, N = 339).
Table 3 presents the number (percentage) of partici-
pants showing reliable improvement, no reliable change,
and reliable worsening comparing PE and WL for
PTSD (top panel) and depression (bottom panel), along
with the results of the 2 Group × 3 Outcome analy-
ses. Fisher’s Exact Tests indicated signiﬁcant differences
between PE and WL conditions for both PTSD and
depression. The follow-up 2 × 2 analyses indicated that,
compared toWL, PE was associated with a greater pro-
portion of participants achieving reliable improvement
for both PTSD (77.6 vs. 22.4%; χ2 (1,N = 234)= 84.31,
P < .001, η2 = .6, 95% CI [.47, .73]) and depression
(78.2 vs. 21.8%; [χ2 (1, N = 217) = 49.33, P < .001,
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TABLE 2. Frequency (percentage) of reliable improvement and reliable worsening for active treatment and WL
conditions
Outcome variable Active treatment WL Statistic P
PTSD
Reliable improvement 240 (91.6%) 36 (36.4%) Fisher’s Exact < .000
No reliable change 22 (8.4%) 55 (55.6%) N = 361
Reliable worsening 0 8 (8.1%)
N 281 99
Depression
Reliable improvement 212 (83.14%) 31 (36.9%) Fisher’s Exact < .000
No reliable change 38 (14.9%) 43 (51.2%) N = 339
Reliable worsening 5 (2%) 10 (11.9%)
N 274 84
Note: Measures of PTSD were the PTSD Symptom Scale Interview (PSS-I) and Clinician Administered PTSD Scale (CAPS), the measure of
depression was the Beck Depression Inventory (BDI). The treatments were prolonged exposure (PE), prolonged exposure combined with stress
inoculation training (PE/SIT), prolonged exposure combinedwith cognitive restructuring (PE/CR), eyemovement desensitization and reprocessing
(EMDR), and cognitive processing therapy (CPT). The control condition was waitlist (WL). See text for the deﬁnitions of reliable change.
TABLE 3. Frequency (percentage) of reliable
improvement and reliable worsening for PE and WL
condition
Outcome variable PE Waitlist Statistic P
PTSD
Reliable improvement 125 (92.6%) 36 (36.4%) Fisher’s <.001
No reliable change 10 (7.4%) 55 (55.6%) Exact
Reliable worsening 0 8 (8.1%) N = 234
N 135 99
Depression
Reliable improvement 111 (83.5%) 31 (36.9%) Fisher’s <.001
No reliable change 20 (15.0%) 43 (51.2%) Exact
Reliable worsening 2 (1.5%) 10 (11.9%) N = 217
N 133 84
Note: Measures of PTSD were the PTSD Symptom Scale Interview
(PSS-I) and Clinician Administered PTSD Scale (CAPS), the mea-
sure of depression was the Beck Depression Inventory (BDI). PE =
prolonged exposure. See text for the deﬁnitions of reliable change.
η2 = .48, 95%CI [.34, .61]]). In addition, compared with
WL, PEwas associated with a smaller proportion of par-
ticipants displaying reliable worsening for both PTSD
(0 vs. 8.1%; Fisher’s Exact Test, P < .01, N = 234) and
depression (1.5 vs. 11.9%; Fisher’s Exact Test, P < .01,
N = 217).
Table 4 presents the number (percentage) of partici-
pants showing reliable improvement, no reliable change,
and reliable worsening comparing PE and combination
treatment for PTSD (top panel) and depression (bot-
tom panel), along with the results of the 2 Group × 3
Outcome analyses. Fisher’s Exact Tests found no signif-
icant differences across treatments for either PTSD or
depression.
ALTERNATIVE EXPLANATIONS
We investigated two methodological variables that
may provide alternative explanations for the above ﬁnd-
ings. The ﬁrst variable we investigated was whether re-
sults differed as function of who conducted the study.
Speciﬁcally, we compared whether studies conducted by
Foa et al.[8,9] were different from studies conducted by
other researchers.[10,11] Second,we investigatedwhether
results were different in studies with high rates of
dropout compared to studies with low rates of dropout.
As there were no cases of reliable worsening of PTSD
symptoms, the outcome variable in these analyses was
reliable worsening of depression symptoms.
Comparison Between Foa et al. Studies and the
Other Two Studies. Because two of the four studies
included here were done by Foa et al.,[8, 9] the present re-
sults could reﬂect differences unique to Foa’s site, with
fewer participants in her studies showing symptomwors-
ening than participants in the other two studies. To in-
vestigate this possibility, we examined whether the rates
of reliable worsening on depression were lower in the
combined studies by Foa et al. compared the combined
studies by Resick et al. and Rothbaum et al. for the PE
andWL conditions (all four studies had both conditions,
thus there is no confounding of treatment conditionwith
site). There were no differences between the studies of
Foa et al. compared to studies by Resick et al. and Roth-
baum et al. on reliable depression symptom worsening
(3.7 vs. 7.4%, χ2 (1, N = 217) = 1.45, P = 0.23, ns, η2 =
.08, 95% CI [0, .21]).
What is the Effect of Differential Dropout?. The
overall dropout rate from PE for the four studies in-
cluded in the current analyseswas 25.8% (range 8 – 34%)
which was signiﬁcantly higher than 10.7% dropouts for
WL (range 0–17%), χ2 (1, N = 293) = 9.66, P < .01,
η2 = .18, 95% CI [.07, .30]. The dropout rate from
the Tarrier et al.[6] study was 17% for imaginal expo-
sure and 11% for cognitive therapy. Accordingly, the
higher rates of reliable symptom worsening following
WL compared to active treatment across all measures in
the present study and the higher rates of PTSD numer-
ical symptom worsening following exposure compared
to cognitive therapy in Tarrier et al.[6] may be related
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TABLE 4. Frequency (percentage) of reliable improvement and reliable worsening for different classes of treatment (pe
and combination treatments)
Outcome variable PE Combination Treatment Statistic P
PTSD
Reliable improvement 125 (92.6%) 115 (90.6%) Fisher’s = .66
No reliable change 10 (7.4%) 12 (9.4%) Exact
Reliable worsening 0 0 N = 262
N 135 127
Depression
Reliable improvement 111 (83.5%) 101 (82.8%) Fisher’s = .91
No reliable change 20 (15.0%) 18 (14.8%) Exact
Reliable worsening 2 (1.5%) 3 (2.5%) N = 255
N 133 122
Note: Measures of PTSD were the PTSD Symptom Scale Interview (PSS-I) and Clinician Administered PTSD Scale (CAPS), the measure of
depression was the Beck Depression Inventory (BDI). PE = prolonged exposure, Combination Treatment = prolonged exposure combined
with SIT (PE/SIT) or cognitive restructuring (PE/CR), cognitive processing therapy (CPT), and eye movement desensitization and reprocessing
(EMDR). See text for the deﬁnitions of reliable change.
to differential dropout across studies and conditions. As
can be seen from Table 1, for PE, the Foa et al.[9] and
Resick et al.[10] studies had higher dropout rates (34 and
27%, respectively) than the Foa et al.[8] and Rothbaum
et al.[11] studies (8 and 13%, respectively). To test the
hypothesis that symptom worsening would be lower in
studies with higher dropout rates, we combined the two
studies with the low dropout rates[8,11] and the two stud-
ies with the higher dropout rates.[9,11] Rates of reliable
depression worsening following PEwere low and similar
for the low dropout rate studies and the higher dropout
rate studies (0 vs. 2.2%, Fisher’s Exact Test, P = .99,
N = 133).
DISCUSSION
In this study, we evaluated pre- to posttreatment
symptom worsening for several empirically supported
therapies to determine whether PE is harmful compared
toWL and compared to other active treatments, speciﬁ-
cally SIT, CPT, EMDR, and PE combined with SIT or
CR.Weutilizeddata from four publishedwell controlled
studies of female assault victims that all included PE and
WL conditions, along with at least one other empirically
supported psychotherapy and we considered both reli-
able improvement and reliable worsening. Treatment
outcome was evaluated for clinician-administered mea-
sures of PTSD (CAPS and PSS-I) and self-reported de-
pression (BDI).
Results revealed a consistent pattern for both PTSD
and depression. First, active treatment in general, and
PE in particular, resulted in a greater percentage of par-
ticipants achieving reliable improvement onmeasures of
PTSDanddepression thanWL. Second, rates of reliable
symptomworseningwere low for treatment participants,
with no cases of reliable worsening of PTSD symptoms;
these rates were signiﬁcantly lower than those found
in WL. Third, there were no signiﬁcant differences
among the different treatments on rates of reliable
improvement or reliable worsening. The exact pattern
of results was observed when we compared PE alone to
WL.
We conducted additional analyses to evaluate two al-
ternative explanations for our ﬁnding that PE is not asso-
ciated with higher rates of reliable worsening on depres-
sion compared to other treatments. First, we examined if
results differed as function of who conducted the study.
It is possible that some aspect of the procedures used
by Foa and colleagues were responsible for the lower
rates of reliable worsening of depression symptoms. As
all four studies included the BDI, we were able to eval-
uate whether the studies by Foa and colleagues showed
lower rates of reliable worsening on depression than the
other two studies. Inconsistent with the explanation that
the studies by Foa and colleagues produced lower rates of
reliable symptom worsening than other researchers, our
results indicated no differences between the two groups
of studies.
We then examined whether rates of reliable wors-
ening on depression were related to rates of dropout.
Speciﬁcally, it could be hypothesized that participants
who experience symptom worsening are more likely to
dropout from treatment. It follows that studies with
higher dropout rates will exhibit lower rates of symptom
worsening. To investigate this possibility, we compared
studies with high and low dropout rates. Inconsistent
with the dropout explanation, our results indicated that
rates of reliable depression symptom worsening follow-
ing PE were not lower in studies with higher rates of
dropout than in studies with lower rates of dropout.
Our results suggest that cognitive-behavior therapy,
including exposure therapy, as well as EMDR are safe
treatments for chronic PTSD among individuals meet-
ing the basic inclusion (i.e. chronic PTSD is the primary
disorder) and exclusion criteria (i.e. not psychotic or ac-
tively dependent on substances other than nicotine, not
actively suicidal and no recent history of self mutilation)
used in these studies.
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We note several caveats. First, the current study drew
its participants from only four randomized controlled
trials. Although the number of participants in the cur-
rent study is quite large, the inclusion of other studies
would have allowed us to make more deﬁnitive conclu-
sions about the safety of PE. Second, our pooled data
set consisted only of females with a history of assault.
The focus on female assault survivors has the advantage
that it makes the four studies included here comparable;
however, it limits the generalizability of our ﬁndings to
other traumatized populations. Third, the reliable im-
provement scores for the PSS-I and CAPS varied based
on the test-retest reliability (4 weeks for the PSS-I vs.
1 week for the CAPS), resulting in a different rubric
used for each measure. It is possible that the estimate of
reliable improvement for the CAPS is too conservative.
However, as noted earlier, Schnurr et al.[23]’s estimate of
reliable change for the CAPS was +/−10 points, similar
to the +/−11.35 used in the current analyses.
Fourth, symptom worsening was the sole measure of
safety examined. Symptom worsening formed the ba-
sis of Tarrier et al.’s[6] concern about PE. However,
other potential adverse effects, (i.e. increased alcohol
use) were systematically collected in only 1 of the 4
studies examined.[10] However, a long-term follow up
evaluation of participants in this study found that pa-
tients who received either PE or CPT did not experi-
ence signiﬁcantly more alcohol dependence 5–10 years
posttreatment.[25]
Fifth, as each study involved random assignment of
participants and each had a PE and WL control group,
randomization was maintained when we pooled the PE
andWLparticipants across studies.However, the studies
differed in the non-PE treatments that were provided.
Thus, randomization is essentially lost when comparing
PE or WL with the non-PE treatments.
Sixth, therewere substantiallymore participants in PE
and WL than in the other treatments, which could bias
results in two opposite ways. On the one hand, given the
overall low rates of symptom worsening, the larger the
sample the more likely it will contain cases of symptom
worsening. On the other hand, even a single case of
symptom worsening in a small sample can yield an in-
ﬂated percentage. For both reasons (randomization and
sample size), our conclusions are stronger for compar-
isons between PE and WL than any other comparisons.
Seventh, our analyses were restricted to study com-
pleters. It is possible that rates of symptom worsening
are higher for those who dropout than for those who
complete treatment. However, when we compared
individuals who dropped out from active treatment,
those who had dropped out from WL in the study with
the largest dropout rate,[9] individuals who dropped
out of treatment fared no worse than individuals who
completed WL. Clinical experience further indicates
that, at least in some cases, participants may drop out
from treatment because they have improved and are no
longermotivated to remain in the study. Consistent with
this possibility, we found nearly 60% of participants
who dropped out of treatment in the Foa et al.[9] study
showed reliable improvement on self-reported PTSD
severity. Similarly, Schnurr et al.[23] found that in their
study comparing PE and present-centered therapy, a
supportive intervention, in a sample of 277 female veter-
ans, 63.8%of thosewhodropped out in thePE condition
achieved PTSD responder status posttreatment (i.e. a
reduction of 10 or more points on the CAPS, similar
to the deﬁnition of reliable improvement on the CAPS
used in the current study, a reduction of 11.35 or more
points).
The above caveats notwithstanding, our results sug-
gest that withholding effective treatment for PTSD is
harmful in two ways. First, a larger proportion of WL
participants showed symptom worsening than partici-
pants who received treatment. Second, fewer WL par-
ticipants showed reliable symptom improvement than
participantswho received treatment.Todate, the discus-
sion around the safety of exposure therapy has focused on
concerns about harm caused through acts of commission
without balancing concerns about harm caused through
acts of omission. Becker-Blease and Freyd[26] have ad-
dressed concerns some researchers have expressed about
assessing research participants for histories of childhood
abuse and discussed both the potential beneﬁts of con-
ducting such assessments and the costs of not conducting
them. We encourage researchers and clinicians alike to
similarly take into consideration the likelihood of caus-
ing harm through withholding treatment (acts of omis-
sion) as well as commission (administering a treatment)
in the design of future research and selection of treat-
ments.
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